Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 18 (RPL32P18)
- Target
- RPL32P18
- Molecular classification
- Pseudogene, Processed pseudogene, Other
01
Overview
Ribosomal protein L32 pseudogene 18 (RPL32P18) is classified as a processed pseudogene in the human genome, meaning it is an inactive, non-protein-coding segment derived from retrotransposition or duplication of the functional RPL32 gene. Processed pseudogenes such as RPL32P18 are common for ribosomal protein genes and are typically dispersed across the genome, containing sequence similarities but lacking the capacity to encode functional protein. They are not implicated in canonical gene functions, disease mechanisms, or as direct drug targets[1][4][6]. Note: This entry is *not* a functional gene, receptor, enzyme, transporter, or any targetable molecular entity relevant to drug discovery or therapeutic intervention. For information on the functional parent gene, see **RPL32 (Ribosomal protein L32)**[3][5].
- Other names
- RPL32_8_807RPL32P18
02
Mechanism of action
None (no drugs target this pseudogene)
03
Biological functions
None (does not encode a functional protein or RNA; no known active biological function)
04
Disease associations
Other (no direct disease association; however, pseudogenes as a class may have indirect relevance in gene regulation or evolutionary biology)
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None specific to this pseudogene
Beyond the preview
Go deeper on Ribosomal protein L32 pseudogene 18 (RPL32P18).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 18 (RPL32P18).